Tags |
|
|
Links |
|
|
Digg It - The Hidden Truth About Online Advertising Revenues
In my role I get to meet literally hundreds of online content publishers every year and the question I'm most frequently asked is:
“Shoul
“Shoul
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
d we give our content away for free and make our money from advertising, or should we charge people to get access to our content?"
Our an
Our an
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
wer is always the same.
“If you can make as much money giving your content away for free and selling advertising space against it, as you
“If you can make as much money giving your content away for free and selling advertising space against it, as you
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
can make from running a paid subscription website, then go the free content route. It is simpler”.
However for 90% of specia
However for 90% of specia
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ist information publishers they will never make as much from advertising revenues as they can from subscriptions and these are the reasons
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
why.
Reason #1 – We Only Hear About the Headline Advertising Figures
Anyone vaguely involved with the int
Reason #1 – We Only Hear About the Headline Advertising Figures
Anyone vaguely involved with the int
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
rnet will frequently see figures being quoted about the size of the online advertising market and how quickly it is growing. But rarely do
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
we see a breakdown of how these revenues are distributed. So here it is:
72% of all online advertising revenues go to just 10 companies
72% of all online advertising revenues go to just 10 companies
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
br>
95% of all online advertising revenues go to just 50 companies
That leaves just 5% of the remaining revenues being distributed among
That leaves just 5% of the remaining revenues being distributed among
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
st tens of thousands of websites which are trying to make money from advertising. And amongst this group who have to pick up the scraps of
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
the rich advertisers table are many big international publishers. They are taking a big chunk of the remaining 5%!
To put some numbers a
To put some numbers a
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ound these facts:
In the US 5% of advertising revenues in 2005 was $620m
In the UK 5% of advertising revenues in 2005 was ?40m
The
In the US 5% of advertising revenues in 2005 was $620m
In the UK 5% of advertising revenues in 2005 was ?40m
The
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
se are not big figures when you take into account how many thousands of websites are trying to get a piece of the action.
Reason
Reason
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
2 – Advertising is Driven by Traffic Volumes
The second reason is, like it or not, online advertising revenues are still largely
The second reason is, like it or not, online advertising revenues are still largely
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
driven by volumes of visitors to a website. The typical rates are $8/?5 per thousand pageviews (even for Adsense). To make $100,000 or ?6
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
,000 in revenue you would need to be getting over 34,000 pageviews a day on your website.
Successful specialist online publications typic
Successful specialist online publications typic
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ally rely on having a low volume of highly interested and loyal readers. This does not suit a volume driven advertising model.
Co
Co
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
clusion
There are only two ways of making money from content on the web. Free with advertising, or paid for access. Advertising
There are only two ways of making money from content on the web. Free with advertising, or paid for access. Advertising
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
is volume driven so does not suit niche sites with low numbers of loyal followers. Therefore content owners have one alternative and that
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
s to charge for the content. They can do this as one off downloads or provide access to content on an ongoing basis for a subscription fee
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/72685/diggit-The-Hidden-Truth-About-Online-Advertising-Revenues.html">The Hidden Truth About Online Advertising Revenues</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/72685/diggit-The-Hidden-Truth-About-Online-Advertising-Revenues.html]The Hidden Truth About Online Advertising Revenues[/url]
Related Articles:
Affiliate Marketing - The Truth About Clickbank Vendor Claims
Bookmark it:
|